TGA Approval

GENRX IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial (246735)

ARTG ID

246735

ARTG Name

GENRX IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Sponsor

Baxter Healthcare Pty Ltd

ARTG Date

May 23, 2016

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BAXTER HEALTHCARE PTY LTD

Ingredient Name

irinotecan hydrochloride trihydrate

Empowering clinical research with data-driven insights and AI-powered tools.

GENRX IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial (246735) - TGA 批准文号 | MedPath